These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

266 related articles for article (PubMed ID: 7329995)

  • 1. Desferrioxamine-induced changes of aluminium kinetics during haemodialysis.
    Graf H; Stummvoll HK; Meisinger V
    Proc Eur Dial Transplant Assoc; 1981; 18():674-80. PubMed ID: 7329995
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of desferrioxamine on aluminum kinetics during hemodialysis.
    Stummvoll HK; Graf H; Meisinger V
    Miner Electrolyte Metab; 1984; 10(4):263-6. PubMed ID: 6749073
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Desferrioxamine induced aluminium removal in haemodialysis.
    Bonal J; Montoliu J; Löpez Pedret J; Bergadä E; Andrew L; Bachs M; Revert L
    Proc Eur Dial Transplant Assoc Eur Ren Assoc; 1985; 21():366-70. PubMed ID: 3991524
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of aluminium intoxication: a new scheme for desferrioxamine administration.
    Douthat WG; Acuña Aguerre G; Fernández Martín JL; Mouzo R; Cannata Andía JB
    Nephrol Dial Transplant; 1994; 9(10):1431-4. PubMed ID: 7816256
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetics of desferrioxamine and of its iron and aluminium chelates in patients on haemodialysis.
    Allain P; Chaleil D; Mauras Y; Beaudeau G; Varin MC; Poignet JL; Ciancioni C; Ang KS; Cam G; Simon P
    Clin Chim Acta; 1987 Dec; 170(2-3):331-8. PubMed ID: 3436066
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Improvement of anaemia with desferrioxamine in haemodialysis patients.
    Praga M; Andrés A; de la Serna J; Ruilope LM; Nieto J; Estenoz J; Millet VG; Arnaiz F; Rodicio JL
    Nephrol Dial Transplant; 1987; 2(4):243-7. PubMed ID: 3118265
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plasma aluminum and iron kinetics in hemodialyzed patients after i.v. infusion of desferrioxamine.
    Ciancioni C; Poignet JL; Mauras Y; Panthier G; Delons S; Allain P; Man NK
    Trans Am Soc Artif Intern Organs; 1984; 30():479-82. PubMed ID: 6533925
    [No Abstract]   [Full Text] [Related]  

  • 8. [Effect of deferoxamine on erythropoiesis in patients hemodialyzed for chronic renal insufficiency treated with erythropoietin].
    Kalinowski M; Popławski A; Kaliszewski Z; Juzwiuk J
    Pol Merkur Lekarski; 1996 Oct; 1(4):232-4. PubMed ID: 9156931
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Aluminum-balance during haemodialysis (author's transl)].
    Graf H; Stummvoll HK; Kovarik J; Meisinger V; Wolf A; Pinggera WF
    Wien Klin Wochenschr; 1980; 92(11):391-4. PubMed ID: 7424016
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Determination of the plasma aluminum concentration of hemodialysis patients].
    Kuleva V; Petrov I; Antonov S; Kiriakov Z
    Vutr Boles; 1984; 23(2):51-5. PubMed ID: 6741112
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Haemofiltration or haemodialysis in aluminium elimination?
    Sulkova S; Laurincova Z; Válek A
    Nephrol Dial Transplant; 1991; 6 Suppl 3():3-5. PubMed ID: 1775263
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Detecting and evaluating hyperaluminemia in 3 dialysis centers].
    Balabán D; Simícková J; Kubátko J; Syrovátka P
    Cas Lek Cesk; 1989 Dec; 128(51):1611-4. PubMed ID: 2631999
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aluminum, zinc and copper concentrations in plasma in chronic renal insufficiency.
    Zumkley H; Bertram HP; Lison A; Knoll O; Losse H
    Clin Nephrol; 1979 Jul; 12(1):18-21. PubMed ID: 477052
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ultrafiltrable aluminium after very low doses of desferrioxamine.
    Canteros A; Díaz-Corte C; Fernández-Martín JL; Gago E; Fernández-Merayo C; Cannata J
    Nephrol Dial Transplant; 1998 Jun; 13(6):1538-42. PubMed ID: 9641189
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Concomitant removal of aluminium and iron by haemodialysis and haemofiltration after desferrioxamine intravenous infusion.
    Ciancioni C; Poignet JL; Naret C; Delons S; Mauras Y; Allain P; Man NK
    Proc Eur Dial Transplant Assoc Eur Ren Assoc; 1985; 21():469-73. PubMed ID: 3991542
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aluminum accumulation in children on chronic dialysis: predictive value of serum aluminum levels and desferrioxamine infusion test.
    Roodhooft AM; van de Vyver FL; D'Haese PC; van Acker KJ; Visser WJ; de Broe ME
    Clin Nephrol; 1987 Sep; 28(3):125-9. PubMed ID: 3665205
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of medication in the level of aluminium in the blood of chronic haemodialysis patients.
    Bohrer D; Bertagnolli DC; de Oliveira SM; do Nascimento PC; de Carvalho LM; Garcia SC; Arantes LC; Barros EJ
    Nephrol Dial Transplant; 2009 Apr; 24(4):1277-81. PubMed ID: 19028749
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Exacerbation of aluminium encephalopathy after treatment with desferrioxamine.
    Lillevang ST; Pedersen FB
    Nephrol Dial Transplant; 1989; 4(7):676. PubMed ID: 2510071
    [No Abstract]   [Full Text] [Related]  

  • 19. The use of intravenous and intraperitoneal desferrioxamine in aluminium osteomalacia.
    O'Brien AA; McParland C; Keogh JA
    Nephrol Dial Transplant; 1987; 2(2):117-9. PubMed ID: 3112649
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Comparison of the effectiveness of hemodialysis and hemofiltration in the removal of aluminum from the body].
    Sulková S; Laurincová Z; Pancírová J; Komonová D; Válek A
    Cas Lek Cesk; 1990 Aug; 129(32):998-1001. PubMed ID: 2208242
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.